Featured Post
Is Your Pharmacy Ready for Compounding Automation?
Compounding automation is transforming how pharmacies produce personalized medicines. But how do you know if your pharmacy is ready to benefit from automated compounding technology?
ROI Video: How Much Time Can a Pharmacist Save in Compounding Using the CurifyLabs Pharma Kit?
ROI on CurifyLabs technology - manual compounding VS automated compounding with the Pharma Kit
Making Personalized Medicine More Accessible: The Case for Automation in Compounding Pharmacies
Compounding non-sterile drugs
-1.png)
The Important Role of Making Custom Medicines to Help with Drug Shortages
Drug shortages and compounding, Delpech Paris
Why hasn't challenges related to manual pharmacy compounding been solved yet?
Medical Faculty University Hospital Magdeburg
How 3D Printing is Transforming Patient-Tailored Pharmacy Preparations
How to use 3D printing in a pharmacy
Introducing new technology to pharmacy students
We believe that it’s important for students to learn about new compounding technologies. In June 2022 CurifyLabs was happy to give a group of pharmacy students at a University the opportunity to use our 3D-printing technology during a laboratory course and to learn how to apply this technology in pharmaceutical compounding.
3D-printed personalized meds are almost here, thanks to this Finnish startup
Pharmaceutical manufacturing is closely linked to mass production. In order for medicines to be sold cheaply, they often have to be made in huge amounts. But what happens if you need a drug in a different dose than what’s being sold? Or a different ingredient in the mix than what’s on offer?
Young citizens represent 100 % of the future of a healthy world
There’s a need for better paediatric medicines as young citizens represent 100 % of the future of a healthy world.
Reducing drug waste for a sustainable future
We think SUDDEN, a research project that aims at reducing the environmental hazards related to the life cycle of pharmaceuticals, is a great Finnish initiative.